Manhattan Genomics Unveils World-Class Scientific Team to Pioneer New Era of Genomic Medicine and Eradicate Inherited Disease
Inherited diseases should not dictate human fate. Today, with advances in genomics, a different future is within reach. In this new era of genomic medicine, Manhattan Genomics, led by serial biotech entrepreneur Cathy Tie and renowned researcher Eriona Hysolli, Ph.D., announced its full scientific contributions team. This world-class group unites pioneers across bioethics, reproductive medicine, and computational genomics to guide the company's mission to advance breakthrough research in preventative genomic therapies.
